1
|
Sahoo P, Choudhary P, Laha SS, Dixit A, Mefford OT. Recent advances in zinc ferrite (ZnFe 2O 4) based nanostructures for magnetic hyperthermia applications. Chem Commun (Camb) 2023; 59:12065-12090. [PMID: 37740338 DOI: 10.1039/d3cc01637d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/24/2023]
Abstract
Spinel ferrite-based magnetic nanomaterials have been investigated for numerous biomedical applications, including targeted drug delivery, magnetic hyperthermia therapy (MHT), magnetic resonance imaging (MRI), and biosensors, among others. Recent studies have found that zinc ferrite-based nanomaterials are favorable candidates for cancer theranostics, particularly for magnetic hyperthermia applications. Zinc ferrite exhibits excellent biocompatibility, minimal toxicity, and more importantly, exciting magnetic properties. In addition, these materials demonstrate a Curie temperature much lower than other transition metal ferrites. By regulating synthesis protocols and/or introducing suitable dopants, the Curie temperature of zinc ferrite-based nanosystems can be tailored to the MHT therapeutic window, i.e., 43-46 °C, a range which is highly beneficial for clinical hyperthermia applications. Furthermore, zinc ferrite-based nanostructures have been extensively used in successful pre-clinical trials on mice models focusing on the synergistic killing of cancer cells involving magnetic hyperthermia and chemotherapy. This review provides a systematic and comprehensive understanding of the recent developments of zinc ferrite-based nanomaterials, including doped particles, shape-modified structures, and composites for magnetic hyperthermia applications. In addition, future research prospects involving pure ZnFe2O4 and its derivative nanostructures have also been proposed.
Collapse
Affiliation(s)
- Priyambada Sahoo
- Advanced Materials and Devices (A-MAD) Laboratory, Department of Physics, Indian Institute of Technology (IIT) Jodhpur, Karwar, Jodhpur, Rajasthan, 342030, India.
| | - Piyush Choudhary
- Advanced Materials and Devices (A-MAD) Laboratory, Department of Physics, Indian Institute of Technology (IIT) Jodhpur, Karwar, Jodhpur, Rajasthan, 342030, India.
| | - Suvra S Laha
- Department of Materials Science & Engineering, Clemson University, Clemson, SC 29634, USA.
| | - Ambesh Dixit
- Advanced Materials and Devices (A-MAD) Laboratory, Department of Physics, Indian Institute of Technology (IIT) Jodhpur, Karwar, Jodhpur, Rajasthan, 342030, India.
| | - O Thompson Mefford
- Department of Materials Science & Engineering, Clemson University, Clemson, SC 29634, USA.
| |
Collapse
|
2
|
Soleymani M, Poorkhani A, Khalighfard S, Velashjerdi M, Khori V, Khodayari S, Khodayari H, Dehghan M, Alborzi N, Agah S, Alizadeh AM. Folic acid-conjugated dextran-coated Zn 0.6Mn 0.4Fe 2O 4 nanoparticles as systemically delivered nano heaters with self-regulating temperature for magnetic hyperthermia therapy of liver tumors. Sci Rep 2023; 13:13560. [PMID: 37604883 PMCID: PMC10442415 DOI: 10.1038/s41598-023-40627-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2022] [Accepted: 08/14/2023] [Indexed: 08/23/2023] Open
Abstract
Successful cancer treatment using magnetic hyperthermia therapy (MHT) strongly depends on biocompatible magnetic nanoparticles (NPs). They can effectively accumulate in tumor tissues after systemic injection and generate heat in the therapeutic temperature range (42-48 °C) by exposure to an AC magnetic field (AMF). For this purpose, folic acid-conjugated dextran-coated Zn0.6Mn0.4Fe2O4 (FA-Dex-ZMF) NPs were synthesized as smart nano heaters with self-regulating temperatures for MHT of liver tumors. Animal studies on BALB/c mice showed that the prepared NPs did not cause acute toxicity upon administration up to 100 mg kg-1. Likewise, no significant changes in hematological and biochemical factors were observed. FA-Dex-ZMF NPs were studied by exposing them to different safe AC magnetic fields (f = 150 kHz, H = 6, 8, and 10 kA m-1). Calorimetric experiments revealed that the NPs reached the desired temperature range (42-48 °C), which was suitable for MHT. Moreover, the efficacy of FA-Dex-ZMF NPs in MHT of liver tumors was investigated in vivo in liver-tumor-bearing mice. The obtained results revealed that the average volume of tumors in the control group increased 2.2 times during the study period. In contrast, the tumor volume remained almost constant during treatment in the MHT group. The results indicated that folic acid-conjugated dextran-coated Zn0.6Mn0.4Fe2O4 NPs with self-regulating temperature could be a promising tool for systemically delivered MHT.
Collapse
Affiliation(s)
- Meysam Soleymani
- Department of Chemical Engineering, Faculty of Engineering, Arak University, Arak, 38156-88349, Iran
| | - Amirhoushang Poorkhani
- Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
| | | | - Mohammad Velashjerdi
- Department of Material Science and Engineering, Faculty of Engineering, Arak University, Arak, 38156-8-8349, Iran
| | - Vahid Khori
- Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
| | - Saeed Khodayari
- International Center for Personalized Medicine, Düsseldorf, Germany
| | - Hamid Khodayari
- International Center for Personalized Medicine, Düsseldorf, Germany
| | - Mohammad Dehghan
- Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
| | - Nazila Alborzi
- Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
| | - Shahram Agah
- Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Ali Mohammad Alizadeh
- Breast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, P.O.: 1419733141, Tehran, Iran.
| |
Collapse
|
3
|
Wang L, Lai SM, Li CZ, Yu HP, Venkatesan P, Lai PS. D-Alpha-Tocopheryl Poly(ethylene Glycol 1000) Succinate-Coated Manganese-Zinc Ferrite Nanomaterials for a Dual-Mode Magnetic Resonance Imaging Contrast Agent and Hyperthermia Treatments. Pharmaceutics 2022; 14:pharmaceutics14051000. [PMID: 35631586 PMCID: PMC9144495 DOI: 10.3390/pharmaceutics14051000] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 04/18/2022] [Accepted: 04/29/2022] [Indexed: 01/26/2023] Open
Abstract
Manganese-zinc ferrite (MZF) is known as high-performance magnetic material and has been used in many fields and development. In the biomedical applications, the biocompatible MZF formulation attracted much attention. In this study, water-soluble amphiphilic vitamin E (TPGS, d-alpha-tocopheryl poly(ethylene glycol 1000) succinate) formulated MZF nanoparticles were synthesized to serve as both a magnetic resonance imaging (MRI) contrast agent and a vehicle for creating magnetically induced hyperthermia against cancer. The MZF nanoparticles were synthesized from a metallic acetylacetonate in an organic phase and further modified with TPGS using an emulsion and solvent-evaporation method. The resulting TPGS-modified MZF nanoparticles exhibited a dual-contrast ability, with a longitudinal relaxivity (35.22 s−1 mM Fe−1) and transverse relaxivity (237.94 s−1 mM Fe−1) that were both higher than Resovist®. Furthermore, the TPGS-assisted MZF formulation can be used for hyperthermia treatment to successfully suppress cell viability and tumor growth after applying an alternating current (AC) electromagnetic field at lower amplitude. Thus, the TPGS-assisted MZF theranostics can not only be applied as a potential contrast agent for MRI but also has potential for use in hyperthermia treatments.
Collapse
Affiliation(s)
- Lin Wang
- College of Chemistry & Pharmacy, Northwest A&F University, Xianyang 712100, China; (L.W.); (H.-P.Y.)
| | - Syu-Ming Lai
- Department of Chemistry, National Chung Hsing University, Taichung 402204, Taiwan; (S.-M.L.); (C.-Z.L.); (P.V.)
| | - Cun-Zhao Li
- Department of Chemistry, National Chung Hsing University, Taichung 402204, Taiwan; (S.-M.L.); (C.-Z.L.); (P.V.)
| | - Hsiu-Ping Yu
- College of Chemistry & Pharmacy, Northwest A&F University, Xianyang 712100, China; (L.W.); (H.-P.Y.)
| | - Parthiban Venkatesan
- Department of Chemistry, National Chung Hsing University, Taichung 402204, Taiwan; (S.-M.L.); (C.-Z.L.); (P.V.)
| | - Ping-Shan Lai
- Department of Chemistry, National Chung Hsing University, Taichung 402204, Taiwan; (S.-M.L.); (C.-Z.L.); (P.V.)
- Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung 402204, Taiwan
- Correspondence:
| |
Collapse
|
4
|
Montha W, Maneeprakorn W, Tang IM, Pon-On W. Hyperthermia evaluation and drug/protein-controlled release using alternating magnetic field stimuli-responsive Mn-Zn ferrite composite particles. RSC Adv 2020; 10:40206-40214. [PMID: 35520877 PMCID: PMC9057567 DOI: 10.1039/d0ra08602a] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2020] [Accepted: 10/23/2020] [Indexed: 01/04/2023] Open
Abstract
Drug delivery particles in which the release of biomolecules is triggered by a magnetic simulant have attracted much attention and may have great potential in the fields of cancer therapy and tissue regenerative medicine. In this study, we have prepared magnetic Mn–Zn ferrite ((Mn,Zn)Fe2O4) (MZF) nanoparticles coated with chitosan-g-N-isopropylacrylamide (Chi-g-NIPAAm) polymer (MZF@Chi-g-NIPAAm) to deliver the anticancer drug (Doxorubicin, DOX) and bioactive proteins (Bone morphogenic protein (BMP-2)-immobilized bovine serum albumin (BSA)) (P//MZF@Chi-g-NIPAAm) and be used as chemo-hyperthermia and vector delivering biomolecules. For these purposes, we first show that the as-prepared MZF@Chi-g-NIPAAm particles exhibit super paramagnetic behavior and under certain conditions, they can act as a heat source with a specific absorption rate (SAR) of 34.88 W g−1. Under acidic conditions and in the presence of AMF, the fast release of DOX was seen at around 58.9% within 20 min. In vitro evaluations indicated that concurrent thermo-chemotherapy treatment by DOX-MZF@Chi-g-NIPAAm using AMF had a better antitumor effect, compared with those using either DOX or DOX-MZF@Chi-g-NIPAAm without AMF (89.02% of cells were killed as compared to 71.82% without AMF exposure). Up to 28.18% of the BSA (used as the model protein to determine the controlled release) is released from the P//MZF@Chi-g-NIPAAm particles under AMF exposure for 1 h (only 17.31% was released without AMF). These results indicated that MZF@Chi-g-NIPAAm particles could be used to achieve hyperthermia at a precise location, effectively enhancing the chemotherapy treatments, and have a promising future as drug or bioactive delivering molecules for cancer treatment and cartilage or bone regenerative applications. Drug delivery particles in which the release of biomolecules is triggered by a magnetic simulant have attracted much attention and may have great potential in the fields of cancer therapy and tissue regenerative medicine.![]()
Collapse
Affiliation(s)
- Wararat Montha
- Department of Physics, Faculty of Science, Kasetsart University Bangkok 10900 Thailand
| | - Weerakanya Maneeprakorn
- National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA) Pathum Thani 12120 Thailand
| | - I-Ming Tang
- Computational & Applied Science doe Smart Innovation Clusters, Faculty of Science, King Mongkut's University of Technology, Thonburi Bangkok 10140 Thailand
| | - Weeraphat Pon-On
- Department of Physics, Faculty of Science, Kasetsart University Bangkok 10900 Thailand
| |
Collapse
|